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background:  Our previous study has demonstrated the pro-survival role of Atorvastatin(ATV) on cardiomyocytes after acute myocardial 
infarction(AMI), but the underlying mechanisms are still unknown. This study aimed to explore whether ATV could have an effect on 
autophagy of cardiomyocytes via the AMPK/mTOR pathway, and to investigate the interaction of autophagy and apoptosis.
methods:  In vivo, ATV(10mg/kg/d) and AMPK inhibitor Compound C(0.2mg/kg/d) were given from 1 week before rat coronary artery 
ligation and reperfusion model were established to 4 weeks after the operation. In vitro, H9C2 cardiomyocytes were exposed to 
ATV(1μmol/L) and Compound C(10μmol/L) treatments and subjected to hypoxia each for 3 hours, were then moved to normal conditions 
for 1 hours of reoxygenation. After the treatment, the cells were harvested and analyzed at 1h, 2h, 4h, 8h, 12h, 24h.
Results:  Compared with the control group, the ATV group increased ejection fraction substantially by 8% four weeks after the operation 
and decreased the infarcted area (P<0.05). ATV treatment increased the AMPK activity and the expression of LC3, Bcl-2 in the reflow 
and no-reflow myocardium (P <0.05) and inhibited the elevation of apoptotic protein as bax, caspase-3. Addition of the AMPK inhibitor 
counteracted these beneficial effects. In vitro, ATV enhanced autophagy and decreased apoptosis in a dose-dependent manner at the 
point of 1h, 2h, 4h . Inhibition of autophagy by knocking down of Atg7 attenuated cell death. In contrast, ATV inhibited both autophagy and 
apoptosis at the point of 8h, 12h, 24h. Inhibition of autophagy accelerated cell death. ATV upregulated AMPK and mTOR phosphorylation. 
However, Compound C abrogated AMPK phosphorylation and decreased autophagy and increased apoptosis.
conclusion:  Atorvastatin facilitates survival of cardiomyocytes, improves function and morphology of infarcted hearts, mediated by 
activation of AMPK pathway. At the early stage of hypoxia/reoxygenation, ATV enhanced autophagy and decreased apoptosis via the 
AMPK/mTOR pathway. However, ATV inhibited both autophagy and apoptosis at the late stage of hypoxia/reoxygenation for protection on 
myocardium.
